Early Initiation of Anti‐TNF Biosimilar in Newly Diagnosed Moderate and Severe Crohn's Disease: Health Economic Insights From the PROFILE Trial

Documenti analoghi

• Nancy Versus Simplified Magnetic Resonance Index of Activity for Crohn's Disease Scores for Crohn's Disease
  di: Astrée Lemore, et al.
  Pubblicazione: (2026)
• Establishing a Central Reader Pool for Magnetic Resonance Enterography Scoring in Crohn's Disease Clinical Trials
  di: Lushen Pillay, et al.
  Pubblicazione: (2026)
• The Crohn's Disease Exclusion Diet Across the Lifespan, Indications and the Globe: An Expert Review Towards Personalized Therapy in Crohn's Disease
  di: Rotem Sigall Boneh, et al.
  Pubblicazione: (2026)
• Vedolizumab in Early and Late Crohn's Disease (LOVE‐CD): A Phase 4 Open‐Label Cohort Study
  di: Catarina Costa
  Pubblicazione: (2026)
• Advancing Clinical Trial Methodology and Reporting of Outcomes for Exclusive Enteral Nutrition and Partial Enteral Nutrition in Crohn's Disease: Challenges and Recommendations
  di: Sarah L. Melton, et al.
  Pubblicazione: (2025)